Riskpilot← Back to searchSign inGet full accessFAM KLINIKK AS
ASActiveOrg 926164899Tordenskiolds Gate 12, 0160 OsloOther human health activities n.e.c. · NACE 8699Est. 20209 employeesfamklinikk.no
Revenue 2024
NOK 5,5M
+39% vs 2023
EBITDA margin
-2.4%
+12% vs 2023
Equity ratio
-25.3%
Financial strength
Net profit 2024
NOK -161K
+14% vs 2023
| Revenue | NOK 5,5M | +39% |
| EBITDA | NOK -130K | +12% |
| Net profit | NOK -161K | +14% |
| Total assets | NOK 1,2M | +56% |
| Equity | NOK -303K | -113% |
| Employees | 9 | — |
Legal name
FAM KLINIKK AS
Org number
926164899
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
11. desember 2020
Share capital
NOK 300 000
Employees
9 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Selge tjenester og varer innen helse - og annet som naturlig sammenfaller med dette - samt deltakelse i andre selskaper, investeringer og nærliggende virksomhet.
Address
Tordenskiolds Gate 12, 0160 Oslo
Website
famklinikk.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 625 | 1 539 | 3 957 | 5 483 |
| Staff expenses | −0 | −278 | −660 | −1 100 | −2 132 |
| EBITDA | 0 | 65 | −300 | −149 | −130 |
| Depreciation & amort. | −0 | −0 | −2 | −7 | −18 |
| EBIT | 0 | 65 | −303 | −156 | −148 |
| Net financials | 0 | 0 | 1 | −31 | −13 |
| Profit before tax | 0 | 65 | −302 | −187 | −161 |
| Tax | −0 | 13 | −0 | −0 | −0 |
| Net profit | 0 | 52 | −302 | −187 | −161 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 26 | 195 | 208 | 768 | 1 201 |
| Equity | 24 | 76 | −225 | −142 | −303 |
| Long-term debt | 0 | 0 | 0 | 100 | 0 |
| Short-term debt | 2 | 119 | 433 | 810 | 1 505 |
| Total debt | 2 | 119 | 433 | 910 | 1 505 |
EBITDA margin
-2.4%
This company
15.8%
Market median
-115% vs market
20202024
Equity ratio
-25.3%
This company
38.2%
Market median
-166% vs market
20202024
Return on equity
-16122800.0%
This company
18.4%
Market median
-87624013% vs market
20202024
Net profit margin
-2.9%
This company
8.1%
Market median
-136% vs market
20202024
Asset turnover
4.56×
This company
1.12×
Market median
+307% vs market
20202024
Debt / equity
4.96×
This company
0.62×
Market median
-700% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MS Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2024 | |
| Company | 50% | 50% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Paddy As
FAM KLINIKK AS Board members of FAM KLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marte Sofie Jæger Waatland | Chief Executive Officer | 0 companies |
| Patrick Wullum | Board of Directors | 0 companies |
| Finn Eliassen | Chairman | 0 companies |